Beijnen JH - Search Results

1

Manufacture of gene-modified human T-cells with a memory stem/central memory phenotype.

Gomez-Eerland R, Nuijen B, Heemskerk B, van Rooij N, van den Berg JH, Beijnen JH, Uckert W, Kvistborg P, Schumacher TN, Haanen JB, Jorritsma A. Gomez-Eerland R, et al. Among authors: beijnen jh. Hum Gene Ther Methods. 2014 Oct;25(5):277-87. doi: 10.1089/hgtb.2014.004. Epub 2014 Sep 22. Hum Gene Ther Methods. 2014. PMID: 25143008 Free PMC article.

2

Photostability profiles of the experimental antimetastatic ruthenium complex NAMI-A.

Bouma M, Nuijen B, Jansen MT, Sava G, Bult A, Beijnen JH. Bouma M, et al. Among authors: beijnen jh. J Pharm Biomed Anal. 2002 Nov 7;30(4):1287-96. doi: 10.1016/s0731-7085(02)00458-2. J Pharm Biomed Anal. 2002. PMID: 12408919

3

A kinetic study of the chemical stability of the antimetastatic ruthenium complex NAMI-A.

Bouma M, Nuijen B, Jansen MT, Sava G, Flaibani A, Bult A, Beijnen JH. Bouma M, et al. Among authors: beijnen jh. Int J Pharm. 2002 Nov 6;248(1-2):239-46. doi: 10.1016/s0378-5173(02)00460-x. Int J Pharm. 2002. PMID: 12429477

4

Development of a LC method for pharmaceutical quality control of the antimetastatic ruthenium complex NAMI-A.

Bouma M, Nuijen B, Jansen MT, Sava G, Picotti F, Flaibani A, Bult A, Beijnen JH. Bouma M, et al. Among authors: beijnen jh. J Pharm Biomed Anal. 2003 Feb 26;31(2):215-28. doi: 10.1016/s0731-7085(02)00313-8. J Pharm Biomed Anal. 2003. PMID: 12609661

5

Pharmaceutical quality control of the investigational polymer-conjugated platinum anticancer agent AP 5280.

Bouma M, Nuijen B, Stewart DR, Shannon KF, St John JV, Rice JR, Harms R, Jansen BA, van Zutphen S, Reedijk J, Bult A, Beijnen JH. Bouma M, et al. Among authors: beijnen jh. PDA J Pharm Sci Technol. 2003 May-Jun;57(3):198-207. PDA J Pharm Sci Technol. 2003. PMID: 12877330

6

Development and validation of a liquid chromatography-ultraviolet absorbance detection assay using derivatisation for the novel marine anticancer agent ES-285 x HCl [(2S,3R)-2-amino-3-octadecanol hydrochloride] and its pharmaceutical dosage form.

den Brok MW, Nuijen B, Miranda E, Floriano P, Munt S, Manzanares I, Beijnen JH. den Brok MW, et al. Among authors: beijnen jh. J Chromatogr A. 2003 Dec 12;1020(2):251-8. doi: 10.1016/j.chroma.2003.08.094. J Chromatogr A. 2003. PMID: 14661748

7

2-Hydroxypropyl-beta-cyclodextrin extracts 2-phenylphenol from silicone tubing.

den Brok MW, van der Schoot SC, Nuijen B, Hillebrand MJ, Beijnen JH. den Brok MW, et al. Among authors: beijnen jh. Int J Pharm. 2004 Jul 8;278(2):303-9. doi: 10.1016/j.ijpharm.2004.03.020. Int J Pharm. 2004. PMID: 15196635

8

Process characterisation, optimisation and validation of production of diacetylmorphine/caffeine sachets: a design of experiments approach.

Klous MG, Nuijen B, Van den Brink W, Van Ree JM, Beijnen JH. Klous MG, et al. Among authors: beijnen jh. Int J Pharm. 2004 Nov 5;285(1-2):65-75. doi: 10.1016/j.ijpharm.2004.07.007. Int J Pharm. 2004. PMID: 15488680

9

Pharmaceutical development of an intravenous dosage form of diacetylmorphine hydrochloride.

Klous MG, Nuijen B, van den Brink W, Van Ree JM, Beijnen JH. Klous MG, et al. Among authors: beijnen jh. PDA J Pharm Sci Technol. 2004 Nov-Dec;58(6):287-95. PDA J Pharm Sci Technol. 2004. PMID: 15663060

10

Pharmaceutical development of a lyophilised dosage form for the investigational anticancer agent Imexon using dimethyl sulfoxide as solubilising and stabilising agent.

den Brok MW, Nuijen B, Lutz C, Opitz HG, Beijnen JH. den Brok MW, et al. Among authors: beijnen jh. J Pharm Sci. 2005 May;94(5):1101-14. doi: 10.1002/jps.20331. J Pharm Sci. 2005. PMID: 15793808

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,513 results

Search Page